刘瑞轩

All filings by 刘瑞轩 on record concern 国际医学, in the capacity of chief executive. We count 3 filings; the first trade dates from 16 March 2022 and the latest from 13 May 2026.

On the market, this insider has only ever bought: 3 purchases, €161k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €56k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. Ninety days after publication, 3 purchases show a median change of -3.6%, with the price up in 33% of them. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 13 May 2026: an open-market purchase of €57k, in 国际医学. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.